Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2012
02/07/2012CA2521612C Non-ionic surfactant comprising polyoxyalkylene glycol hydroxy fatty acid derivatives for solubilizing poorly soluble molecules
02/07/2012CA2519351C Controlled release system
02/07/2012CA2516816C Transmucosal drug delivery system
02/07/2012CA2513502C Partially biodegradable temperature and ph sensitive hydrogel
02/07/2012CA2511521C Drug delivery from rapid gelling polymer composition
02/07/2012CA2506593C High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
02/07/2012CA2480826C Oral pharmaceutical formulation in the form of microcapsule aqueous suspension allowing modified release of active ingredient(s)
02/07/2012CA2479057C Compressed tablets comprising microcapsules with modified release
02/07/2012CA2471046C Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
02/07/2012CA2466536C Transdermal transport of compounds
02/07/2012CA2451709C Chewing gum to control malodorous breath
02/02/2012WO2012016229A2 Oxytocin treatment to improve memory and modify blood glucose
02/02/2012WO2012016181A2 Anti-allergy lozenges
02/02/2012WO2012016000A2 Preservative free brimonidine and timolol solutions
02/02/2012WO2012015998A2 Preservative free bimatoprost and timolol solutions
02/02/2012WO2012015996A2 Preservative free bimatoprost solutions
02/02/2012WO2012015979A2 Hmgb1-derived peptides enhance immune response to antigens
02/02/2012WO2012015969A1 Compositions and methods for increased delivery of coenzyme q10
02/02/2012WO2012015910A2 Use of adnf polypeptides for treating neurodegenerative diseases
02/02/2012WO2012015789A2 Composition and method for the topicaltreatment of dermatitis
02/02/2012WO2012015534A1 A method of controlling the release of an active ingredient from a dosage form
02/02/2012WO2012015487A1 Combination of dapsone with adapalene
02/02/2012WO2012015325A1 Stabilized immune correction drug viferon-forte for the treatment of infectious inflammatory diseases
02/02/2012WO2012015323A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids
02/02/2012WO2012015125A1 Stimulus sensitive magnetic nanocomposite using pyrene polymer, and contrast medium composition containing the nanocomposite
02/02/2012WO2012015043A1 Liquid pharmaceutical composition
02/02/2012WO2012014986A1 Drug support body, and method for producing same
02/02/2012WO2012014630A1 Astaxanthin-containing aqueous composition, cosmetic preparation, and method for suppressing degradation of astaxanthin
02/02/2012WO2012014589A1 Adhesive patch for medical use
02/02/2012WO2012014586A1 Adhesive patch for medical use
02/02/2012WO2012014492A1 Immunity inducer
02/02/2012WO2012014238A1 Composition for the treatment and prevention of herpes simplex labialis
02/02/2012WO2012014104A2 Composition comprising shellac and/or a salt thereof and sodium starch glycolate
02/02/2012WO2012014052A2 Novel coated extended release pharmaceutical compositions containing paliperidone
02/02/2012WO2012014016A1 Method of treating animal drinking water with interval dosing of a biocide
02/02/2012WO2012014012A1 Method for producing tablets that dissolve rapidly in the mouth and that include form i of olanzapine, resulting tablets and use thereof in the treatment of schizophrenia
02/02/2012WO2012014011A1 Compositions comprising polymers prepared from 2-hydroxyalkyl acids
02/02/2012WO2012013994A2 Ph-dependent gradual release pharmaceutical composition
02/02/2012WO2012013928A1 Compositions
02/02/2012WO2012013792A1 A transmucosal composition containing anthocyanins for alleviating a visual discomfort
02/02/2012WO2012013791A1 Compositions for treating heartworm infestation
02/02/2012WO2012013756A2 Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol
02/02/2012WO2012013742A2 Stabilization of fsh
02/02/2012WO2012013704A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
02/02/2012WO2012013595A1 Three-phase controlled-release tablet comprising melatonin and process of preparation
02/02/2012WO2012013551A1 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain
02/02/2012WO2012013515A2 Skin patch having optimized active substance release
02/02/2012WO2012013495A1 Pharmaceutical and/or dietary compositions based on short chain fatty acids
02/02/2012WO2012013472A1 Modular microneedle transport device
02/02/2012WO2012013331A2 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
02/02/2012WO2012013229A1 Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system.
02/02/2012WO2012013117A1 Pharmaceutical composition of temozolomide comprising vitamin c or vitamin c derivative and preparation method thereof
02/02/2012WO2012013116A1 Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof
02/02/2012WO2012013088A1 Dronedarone solid dispersion and preparation method thereof
02/02/2012WO2012012857A2 Surfactant-free oil-in-water type emulsion, process for preparation thereof and its uses
02/02/2012WO2011163328A3 Methods for producing tissue scaffold directing differentiation of seeded cells and tissue scaffolds produced thereby
02/02/2012WO2011156895A3 Porous magnetic nanoparticles and uses thereof formed by incomplete hydrolysis
02/02/2012WO2011152804A3 Process for dry powder formulations
02/02/2012WO2011144746A3 Liquid nasal spray containing low-dose naltrexone
02/02/2012WO2011141721A3 Compositions
02/02/2012WO2011135580A3 Pharmaceutical compositions of sirolimus
02/02/2012WO2011134937A3 Pharmaceutical emulsion compositions comprising progestogen
02/02/2012WO2011129627A3 Docetaxel-loaded thermosensitive liquid suppository composition for rectal administration
02/02/2012WO2011129588A3 Polymer/liposome nanocomposite composition for percutaneous absorption, and method for preparing same
02/02/2012WO2011129579A3 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
02/02/2012WO2011129549A3 Anticancer drug delivery system using ph-sensitive metal nanoparticles
02/02/2012WO2011127302A3 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
02/02/2012WO2011127290A3 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
02/02/2012WO2011127241A3 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
02/02/2012WO2011127048A3 NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
02/02/2012WO2011126327A3 Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
02/02/2012WO2011113019A3 Ctla4 proteins and their uses
02/02/2012WO2011109732A3 Reverse thermal gels and uses therefor
02/02/2012WO2011105736A3 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same
02/02/2012WO2011093812A3 Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
02/02/2012WO2011091065A8 Synthetic nanostructures including nucleic acids and/or other entities
02/02/2012WO2011069484A3 Dermal, antimicrobial foot cream
02/02/2012WO2011064558A3 Pharmaceutical composition
02/02/2012US20120029626 Drug delivery endovascular stent and method of use
02/02/2012US20120028949 Rapidly Disintegrating Tablet
02/02/2012US20120028222 Characterization of an antibiotic imregnated delivery systems as an intracanal medicament in endodontic therapy
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027866 Method of preparing a granular delivery system
02/02/2012US20120027865 Water Dispersible Glyceryl Monooleate Magnetic Nanoparticle Formulation
02/02/2012US20120027864 Coated drug delivery formulations
02/02/2012US20120027863 Pharmaceutical Compositions for Inhalation
02/02/2012US20120027862 Azelaic acid-comprising formulation with added pigment
02/02/2012US20120027861 Nano-carrier, complex of anticancer drug and nano-carrier, pharmaceutical composition thereof, method for manufacturing the complex, and method for treating cancer by using the pharmaceutical composition
02/02/2012US20120027860 Encapsulated adipose-derived stem cells, methods for preparation and theraputic use
02/02/2012US20120027859 Biodegradable Proline-Based Polymers
02/02/2012US20120027858 Methods and Compositions for Managing Cancer Cell Growth
02/02/2012US20120027857 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine
02/02/2012US20120027856 Pharmaceutical product comprising yeast
02/02/2012US20120027855 Pharmaceutical compositions for gastrointestinal drug delivery
02/02/2012US20120027854 Pharmaceutical composition comprising ezetimibe and simvastatin
02/02/2012US20120027853 Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
02/02/2012US20120027852 Pharmaceutical composition containing a "limus" family immunosuppressive macrolide
02/02/2012US20120027851 Method of reducing somnolence in patients treated with tizanidine
02/02/2012US20120027850 Compositions and Methods for Treatment of Aortic Fibrosis
02/02/2012US20120027849 Stable pharmaceutical composition for atherosclerosis
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 2991